Trade CELZ anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Creative Medical Technology Holdings, Inc. (CELZ) is trading at US$1.15, up 0.53% today as of Aug 28, 12:34 EDT. The company has a market capitalisation of US$8.64M. Over the past 52 weeks, CELZ has traded between US$0.62 and US$6.25. On Syfe you can trade CELZ with $0 commission and add it to your watchlist.
| Previous close | US$1.14 |
|---|---|
| Market cap | US$8.64M |
| 52-week range | US$0.62 – US$6.25 |
| Volume | 247.91K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. Its products include CaverStem, FemCelz, StemSpine and ImmCelz. The company was founded by Timothy Warbington on December 3, 1998 and is headquartered in Phoenix, AZ.
Year: 2009
Top Premarket Decliners
Jun 26, 11:27 AM · MT Newswires
Creative Medical Files for Securities Offering
Jun 25, 9:56 PM · MT Newswires
Creative Medical Technology Expands Phase 2 Trial of Olastrocel in Chronic Lower Back Pain
Jun 22, 1:52 PM · MT Newswires
Creative Medical Technology Holdings, Inc. (CELZ) stock is trading at US$1.15, +0.53% from the previous close of US$1.14.
The market cap for Creative Medical Technology Holdings, Inc. (CELZ) stock is approximately US$8.64M.
The 52-week high for Creative Medical Technology Holdings, Inc. (CELZ) stock is US$6.25.
The 52-week low for Creative Medical Technology Holdings, Inc. (CELZ) stock is US$0.62.
Creative Medical Technology Holdings, Inc. (CELZ) does not currently pay a dividend.
Stay on top of CELZ
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
